Archived articles

Drug policy

Jacqueline Hackett

Changemakers

Policy solutions to combat addiction

Published Aug 16, 2023

Jacqueline Hackett, who earned a MPH from the Johns Hopkins Bloomberg School of Public Health, serves as deputy chief of staff for the White House Office of National Drug Control Policy

Manufacturer's rendering of Aduhelm packaging

Q+A

Insights on FDA's controversial approval of Alzheimer's drug

Published June 21, 2021

Supriya Munshaw, an expert in drug commercialization, discusses what factors went into the FDA approval of aducanumab, a drug known by the brand name Aduhelm

Psychedelic mushrooms

Q+A

The path forward for legal medical mushrooms

Published Dec 2, 2020

Johns Hopkins researcher Matthew Johnson discusses the future for psychedelics research in light of Oregon's measure to legalize psilocybin for clinical use

Safe consumption site needles

Drug policy

Five things to know about overdose prevention sites

Published Feb 12, 2020

Research suggests that the facilities are safe and cost effective, but bringing them to the U.S. has been controversial

Packaged syringe

Drug policy

A look inside early efforts to create safe consumption sites in the U.S.

Published Feb 22, 2019

Study analyzes early policy efforts, identifies challenges and paths forward / School of Public Health

Epidiolex bottles

Medical marijuana

A sea change in CBD drug policy?

Published Oct 2, 2018

The DEA announced a shift Friday that clears the way for the first prescription drug derived from the marijuana plant to make its way to market